Global Gastrointestinal Stent Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, and Pancreatic Stent.

By Application;

Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, and Other.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn108393163 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Gastrointestinal Stent Market (USD Million), 2021 - 2031

In the year 2024, the Global Gastrointestinal Stent Market was valued at USD 495.61 million. The size of this market is expected to increase to USD 698.77 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.

The global gastrointestinal stent market is a dynamic and rapidly evolving sector within the broader medical device industry. Gastrointestinal stents are tubular medical devices used to maintain the patency of the gastrointestinal tract, primarily in cases of obstruction caused by various conditions such as cancer, strictures, or other benign diseases. These stents are designed to provide relief to patients by restoring normal bowel function and alleviating symptoms such as pain and discomfort associated with gastrointestinal obstructions. With advancements in medical technology and an increasing prevalence of gastrointestinal disorders worldwide, the demand for gastrointestinal stents continues to grow, driving innovation and competition among manufacturers.

One of the key drivers of the global gastrointestinal stent market is the rising incidence of gastrointestinal cancers and other diseases that lead to obstruction of the digestive tract. As the global population ages and lifestyles evolve, there has been a notable increase in the prevalence of conditions such as colorectal cancer, pancreatic cancer, and esophageal cancer, all of which may require the use of gastrointestinal stents for palliative or therapeutic purposes.The adoption of screening programs and improved diagnostic techniques have led to earlier detection of gastrointestinal disorders, further fueling the demand for stent placement procedures.

Technological advancements in gastrointestinal stent design and materials have significantly improved the efficacy and safety of these devices, contributing to their growing acceptance among healthcare professionals and patients alike. Modern gastrointestinal stents are typically made from biocompatible materials such as nitinol or cobalt-chromium alloys, offering enhanced flexibility, radial strength, and resistance to migration within the gastrointestinal tract. Furthermore, the development of self-expanding stents with innovative deployment mechanisms has simplified the insertion procedure and reduced the risk of complications, leading to improved patient outcomes and shorter hospital stays.

Despite the many benefits associated with gastrointestinal stent placement, challenges remain in terms of procedural complexities, device-related complications, and reimbursement issues. Endoscopic placement of gastrointestinal stents requires specialized training and expertise, and complications such as stent migration, perforation, or tissue ingrowth may occur in some cases, necessitating additional interventions. Moreover, variations in healthcare policies and reimbursement systems across different regions pose challenges for market players seeking to penetrate new markets or expand their product offerings. Nevertheless, with ongoing research and development efforts focused on addressing these challenges and improving the performance of gastrointestinal stents, the market is poised for continued growth and innovation in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global Gastrointestinal Stent Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Incidence of Gastrointestinal Disorders
        2. Growing Aging Population
        3. Advancements in Stent Technology
      2. Restraints
        1. Complications Associated with Stent Placement
        2. Stringent Regulatory Requirements
        3. Risk of Stent-related Complications
      3. Opportunities
        1. Strategic Collaborations and Partnerships
        2. Focus on Training and Education
        3. Personalized Medicine Approach
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Gastrointestinal Stent Market, By Product Type, 2021- 2031(USD Million)
      1. Biliary Stent
      2. Colonic Stent
      3. Duodenal Stent
      4. Esophageal Stent
      5. Pancreatic Stent
    2. Global Gastrointestinal Stent Market, By Application, 2021- 2031(USD Million)
      1. Biliary Disease
      2. Colorectal Cancer
      3. Stomach Cancer
      4. Inflammatory Bowel Disease
      5. Othe
    3. Global Gastrointestinal Stent Market, By Geography, 2021- 2031(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Cook Group Inc
      3. CR Bard Inc (Becton Dickinson and Company)
      4. CONMED Corporation
      5. Cantel Medical Corporation
      6. ELLA - CS s.r.o
      7. Hobbs Medical Inc
      8. Merit Medical Systems Inc
      9. Olympus Corporation
      10. Diagmed Healthcare
  7. Analyst Views
  8. Future Outlook of the Market